Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Sunitinib Therapy in Patients With Metastatic Clear Cell Type Renal Cell Carcinoma Patients: a Prospective Study

NCT01069770 is registered in ClinicalTrials.gov with Korean Urological Oncology Society as lead sponsor.

NCT NCT01069770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Sunitinib Therapy in Patients With Metastatic Clear Cell Type Renal Cell Carcinoma Patients: a Prospective Study
Lead sponsor
Korean Urological Oncology Society
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2009
Completion date
June 30, 2012
Enrollment
32 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, metastasis